Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Eikon Therapeutics, Inc. Common StockUS flagNASDAQ Global Market
9.91
USD
+0.26
- -
29.24MMarket Cap

Income Statement (USD)

APIChatGPT
2023 Y
2024 Y
2025 Y
As of date
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- Cost of Revenue
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
Gross Profit
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- Operating Expenses
266
260
339
+ Selling, General & Admin
58
56
89
+ Research & Development
207
205
250
+ Other Operating Expense
- -
- -
- -
Operating Income (Loss)
-266
-260
-339
- Non-Operating (Income) Loss
-24
-17
-15
+ Interest Expense, Net
-24
-17
-15
+ Interest Expense
- -
- -
1
- Interest Income
24
17
16
+ Other Non-Op (Income) Loss
- -
- -
- -
Pretax Income
-242
-244
-324
- Income Tax Expense (Benefit)
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
Income (Loss) from Cont Ops
-242
-244
-324
- Net Extraordinary Losses (Gains)
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
Income (Loss) Incl. MI
-242
-244
-324
- Minority Interest
- -
- -
- -
Net Income, GAAP
-242
-244
-324
- Preferred Dividends
- -
- -
- -
- Other Adjustments
- -
- -
- -
Net Income Avail to Common, GAAP
-242
-244
-324
EBIT
-266
-260
-339
EBITDA
-248
-235
-315
EBITDA Margin (%)
- -
- -
- -
EBITA
-266
-260
-339
Gross Margin (%)
- -
- -
- -
Operating Margin (%)
- -
- -
- -
Profit Margin (%)
- -
- -
- -
Sales per Employee
- -
- -
- -
Dividend per Share
- -
- -
- -
Depreciation Expense
18
25
24
Basic Weighted Avg Shares
33
33
54
Basic EPS, GAAP
-7.4
-7.45
-6.01
Basic EPS from Cont Ops
-7.4
-7.45
-6.01
Diluted Weighted Avg Shares
33
33
54
Diluted EPS, GAAP
-7.4
-7.45
-6.01
Diluted EPS from Cont Ops
-7.4
-7.45
-6.01

Balance Sheet (USD)

APIChatGPT
2023 Y
2024 Y
2025 Y
As of date
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
436
228
349
+ Cash, Cash Equivalents & STI
430
220
336
+ Cash & Cash Equivalents
113
129
105
+ ST Investments
318
91
231
+ Accounts & Notes Receiv
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
+ Inventories
- -
- -
- -
+ Raw Materials
- -
- -
- -
+ Work In Process
- -
- -
- -
+ Finished Goods
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
+ Other Inventory
- -
- -
- -
+ Other ST Assets
6
8
13
+ Misc ST Assets
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
Total Noncurrent Assets
89
263
246
+ Property, Plant & Equip, Net
87
259
234
+ Property, Plant & Equip
106
293
277
- Accumulated Depreciation
19
34
43
+ LT Investments & Receivables
- -
- -
- -
+ LT Investments
- -
- -
- -
+ LT Receivables
- -
- -
- -
+ Other LT Assets
2
4
12
+ Total Intangible Assets
- -
- -
- -
+ Goodwill
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
+ Misc LT Assets
2
4
12
Total Assets
526
491
595
+ Payables & Accruals
26
47
45
+ Accounts Payable
2
18
1
+ Accrued Taxes
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
+ Other Payables & Accruals
24
29
44
+ ST Debt
5
9
10
+ ST Borrowings
- -
- -
- -
+ ST Finance Leases
5
9
10
+ Other ST Liabilities
1
- -
- -
+ Deferred Revenue
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
+ Misc ST Liabilities
1
- -
- -
Total Current Liabilities
31
56
55
+ LT Debt
27
193
247
+ LT Borrowings
- -
- -
- -
+ LT Finance Leases
27
193
247
+ Other LT Liabilities
809
814
1,171
+ Accrued Liabilities
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
+ Misc LT Liabilities
809
814
1,171
Total Noncurrent Liabilities
836
1,007
1,419
Total Liabilities
867
1,063
1,474
+ Preferred Equity and Hybrid Capital
- -
- -
- -
+ Share Capital & APIC
20
33
41
+ Common Stock
- -
- -
- -
+ Additional Paid in Capital
20
33
41
- Treasury Stock
- -
- -
- -
+ Retained Earnings
-361
-605
-921
+ Other Equity
- -
- -
- -
Equity Before Minority Interest
-341
-572
-879
+ Minority/Non Controlling Interest
- -
- -
- -
Total Equity
-341
-572
-879
Total Liabilities & Equity
526
491
595
Shares Outstanding
54
54
54
Number of Employees
- -
- -
- -
Capital Leases - Total
32
202
257
Net Debt
-113
-129
-105
Net Debt to Equity
33.04
22.59
11.93
Tangible Common Equity Ratio
-64.94
-116.43
-147.8
Current Ratio
13.88
4.04
6.34
Cash Conversion Cycle
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2023 Y
2024 Y
2025 Y
As of date
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-242
-244
-324
+ Depreciation & Amortization
18
25
24
+ Non-Cash Items
23
3
34
+ Stock-Based Compensation
10
12
18
+ Deferred Income Taxes
- -
- -
- -
+ Asset Impairment Charge
- -
- -
21
+ Other Non-Cash Adj
14
-9
-6
+ Chg in Non-Cash Work Cap
10
81
78
+ (Inc) Dec in Accts Receiv
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-2
-1
-5
+ Inc (Dec) in Accts Payable
17
8
13
+ Inc (Dec) in Other
-6
74
70
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Operating Activities
-191
-135
-189
+ Change in Fixed & Intang
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
+ Acq of Fixed & Intang
-29
-85
-47
+ Acq of Fixed Prod Assets
-29
-85
-47
+ Acq of Intangible Assets
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
2
+ Increase in Capital Stock
- -
- -
2
+ Decrease in Capital Stock
- -
- -
- -
+ Net Change in LT Investment
165
236
-135
+ Dec in LT Investment
970
596
310
+ Inc in LT Investment
-805
-360
-444
+ Net Cash From Acq & Div
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
+ Cash for JVs
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Investing Activities
137
151
-181
+ Dividends Paid
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
+ Cash From Debt
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
+ Other Financing Activities
105
- -
350
+ Net Cash From Disc Ops
- -
- -
- -
Cash from Financing Activities
106
- -
352
Effect of Foreign Exchange Rates
- -
- -
- -
Net Changes in Cash
52
17
-18
EBITDA
-248
-235
-315
EBITDA Margin (%)
- -
- -
- -
Free Cash Flow
-219
-220
-235
Net Cash Paid for Acquisitions
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
Free Cash Flow to Equity
- -
-220
-235
Free Cash Flow per Basic Share
-6.71
-6.71
-4.36
Price/Free Cash Flow
- -
- -
- -
Cash Flow to Net Income
0.79
0.55
0.58
Capital Expenditures
-29
-85
-47